Summit Therapeutics, Inc. (SMMT)
15.94
+0.07
(+0.44%)
USD |
NASDAQ |
Feb 20, 16:00
15.74
-0.20
(-1.25%)
Pre-Market: 20:00
Summit Therapeutics Market Cap : 11.87B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 952.34B |
| Exelixis, Inc. | 11.33B |
| Insmed, Inc. | 35.17B |
| Madrigal Pharmaceuticals, Inc. | 9.880B |
| Soleno Therapeutics, Inc. | 2.114B |
Market Cap Related Metrics
| PEG Ratio | -0.0368 |
| Price to Book Value | 61.72 |
| Price | 15.94 |
| Earnings Yield | -7.79% |
| PEGY Ratio | -0.0368 |